Free Trial
→ Wall Street’s $3.3B critical mineral darling just got spanked by a $300M junior … (From i2i Marketing Group, LLC) (Ad)tc pixel Free CREO Stock Alerts

Creo Medical Group (CREO) Competitors

Creo Medical Group logo
GBX 14.25 -0.25 (-1.72%)
As of 12:12 PM Eastern
Compare

CREO vs. EKF, IUG, NCYT, IHC, and RUA

Should you buy Creo Medical Group stock or one of its competitors? MarketBeat compares Creo Medical Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Creo Medical Group include EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), and RUA Life Sciences (RUA). These companies are all part of the "medical devices" industry.

How does Creo Medical Group compare to EKF Diagnostics?

EKF Diagnostics (LON:EKF) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

22.6% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 45.2% of Creo Medical Group shares are owned by institutional investors. 39.7% of EKF Diagnostics shares are owned by company insiders. Comparatively, 4.1% of Creo Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Creo Medical Group had 9 more articles in the media than EKF Diagnostics. MarketBeat recorded 9 mentions for Creo Medical Group and 0 mentions for EKF Diagnostics. Creo Medical Group's average media sentiment score of 0.37 beat EKF Diagnostics' score of 0.00 indicating that Creo Medical Group is being referred to more favorably in the news media.

Company Overall Sentiment
EKF Diagnostics Neutral
Creo Medical Group Neutral

EKF Diagnostics has a beta of 0.526, indicating that its stock price is 47% less volatile than the broader market. Comparatively, Creo Medical Group has a beta of 1.6238419, indicating that its stock price is 62% more volatile than the broader market.

EKF Diagnostics currently has a consensus price target of GBX 35, indicating a potential upside of 32.18%. Creo Medical Group has a consensus price target of GBX 40, indicating a potential upside of 179.72%. Given Creo Medical Group's higher probable upside, analysts clearly believe Creo Medical Group is more favorable than EKF Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EKF Diagnostics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Creo Medical Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Creo Medical Group has a net margin of 88.33% compared to EKF Diagnostics' net margin of 4.12%. Creo Medical Group's return on equity of 9.56% beat EKF Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
EKF Diagnostics4.12% 3.01% 5.27%
Creo Medical Group 88.33%9.56%-20.09%

EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EKF Diagnostics£51.56M2.21£4.68M£0.4756.34
Creo Medical Group£6M9.83-£25.04M-£1.00N/A

Summary

EKF Diagnostics and Creo Medical Group tied by winning 8 of the 16 factors compared between the two stocks.

How does Creo Medical Group compare to Intelligent Ultrasound Group?

Intelligent Ultrasound Group (LON:IUG) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Intelligent Ultrasound Group has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than Intelligent Ultrasound Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intelligent Ultrasound Group£6.57M0.00-£2.27M-£0.68N/A
Creo Medical Group£6M9.83-£25.04M-£1.00N/A

In the previous week, Creo Medical Group had 9 more articles in the media than Intelligent Ultrasound Group. MarketBeat recorded 9 mentions for Creo Medical Group and 0 mentions for Intelligent Ultrasound Group. Creo Medical Group's average media sentiment score of 0.37 beat Intelligent Ultrasound Group's score of 0.00 indicating that Creo Medical Group is being referred to more favorably in the news media.

Company Overall Sentiment
Intelligent Ultrasound Group Neutral
Creo Medical Group Neutral

75.5% of Intelligent Ultrasound Group shares are held by institutional investors. Comparatively, 45.2% of Creo Medical Group shares are held by institutional investors. 12.8% of Intelligent Ultrasound Group shares are held by company insiders. Comparatively, 4.1% of Creo Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Creo Medical Group has a net margin of 88.33% compared to Intelligent Ultrasound Group's net margin of -23.11%. Creo Medical Group's return on equity of 9.56% beat Intelligent Ultrasound Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Intelligent Ultrasound Group-23.11% -23.58% -13.51%
Creo Medical Group 88.33%9.56%-20.09%

Intelligent Ultrasound Group has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market. Comparatively, Creo Medical Group has a beta of 1.6238419, indicating that its stock price is 62% more volatile than the broader market.

Summary

Intelligent Ultrasound Group and Creo Medical Group tied by winning 6 of the 12 factors compared between the two stocks.

How does Creo Medical Group compare to Novacyt?

Novacyt (LON:NCYT) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Creo Medical Group has a net margin of 88.33% compared to Novacyt's net margin of -135.96%. Creo Medical Group's return on equity of 9.56% beat Novacyt's return on equity.

Company Net Margins Return on Equity Return on Assets
Novacyt-135.96% -111.34% -27.98%
Creo Medical Group 88.33%9.56%-20.09%

10.7% of Novacyt shares are owned by institutional investors. Comparatively, 45.2% of Creo Medical Group shares are owned by institutional investors. 0.5% of Novacyt shares are owned by insiders. Comparatively, 4.1% of Creo Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Novacyt has a beta of 0.973, meaning that its share price is 3% less volatile than the broader market. Comparatively, Creo Medical Group has a beta of 1.6238419, meaning that its share price is 62% more volatile than the broader market.

Creo Medical Group has lower revenue, but higher earnings than Novacyt. Creo Medical Group is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novacyt£20.03M1.85-£36.80M-£43.00N/A
Creo Medical Group£6M9.83-£25.04M-£1.00N/A

In the previous week, Creo Medical Group had 8 more articles in the media than Novacyt. MarketBeat recorded 9 mentions for Creo Medical Group and 1 mentions for Novacyt. Novacyt's average media sentiment score of 0.84 beat Creo Medical Group's score of 0.37 indicating that Novacyt is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Novacyt
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Creo Medical Group
0 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Creo Medical Group beats Novacyt on 10 of the 13 factors compared between the two stocks.

How does Creo Medical Group compare to Inspiration Healthcare Group?

Inspiration Healthcare Group (LON:IHC) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

In the previous week, Creo Medical Group had 9 more articles in the media than Inspiration Healthcare Group. MarketBeat recorded 9 mentions for Creo Medical Group and 0 mentions for Inspiration Healthcare Group. Creo Medical Group's average media sentiment score of 0.37 beat Inspiration Healthcare Group's score of 0.00 indicating that Creo Medical Group is being referred to more favorably in the news media.

Company Overall Sentiment
Inspiration Healthcare Group Neutral
Creo Medical Group Neutral

8.2% of Inspiration Healthcare Group shares are owned by institutional investors. Comparatively, 45.2% of Creo Medical Group shares are owned by institutional investors. 8.4% of Inspiration Healthcare Group shares are owned by insiders. Comparatively, 4.1% of Creo Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Inspiration Healthcare Group has a beta of 0.717, indicating that its share price is 28% less volatile than the broader market. Comparatively, Creo Medical Group has a beta of 1.6238419, indicating that its share price is 62% more volatile than the broader market.

Inspiration Healthcare Group has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than Inspiration Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspiration Healthcare Group£45.20M0.58-£12.20M-£13.65N/A
Creo Medical Group£6M9.83-£25.04M-£1.00N/A

Creo Medical Group has a net margin of 88.33% compared to Inspiration Healthcare Group's net margin of -25.32%. Creo Medical Group's return on equity of 9.56% beat Inspiration Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspiration Healthcare Group-25.32% -69.35% -3.47%
Creo Medical Group 88.33%9.56%-20.09%

Summary

Creo Medical Group beats Inspiration Healthcare Group on 8 of the 13 factors compared between the two stocks.

How does Creo Medical Group compare to RUA Life Sciences?

Creo Medical Group (LON:CREO) and RUA Life Sciences (LON:RUA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

In the previous week, Creo Medical Group had 9 more articles in the media than RUA Life Sciences. MarketBeat recorded 9 mentions for Creo Medical Group and 0 mentions for RUA Life Sciences. Creo Medical Group's average media sentiment score of 0.37 beat RUA Life Sciences' score of 0.00 indicating that Creo Medical Group is being referred to more favorably in the media.

Company Overall Sentiment
Creo Medical Group Neutral
RUA Life Sciences Neutral

45.2% of Creo Medical Group shares are owned by institutional investors. Comparatively, 0.1% of RUA Life Sciences shares are owned by institutional investors. 4.1% of Creo Medical Group shares are owned by insiders. Comparatively, 7.3% of RUA Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

RUA Life Sciences has lower revenue, but higher earnings than Creo Medical Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Creo Medical Group£6M9.83-£25.04M-£1.00N/A
RUA Life Sciences£4.11M3.00-£2.66MN/AN/A

Creo Medical Group has a beta of 1.6238419, indicating that its share price is 62% more volatile than the broader market. Comparatively, RUA Life Sciences has a beta of 0.968, indicating that its share price is 3% less volatile than the broader market.

Creo Medical Group has a net margin of 88.33% compared to RUA Life Sciences' net margin of -3.26%. Creo Medical Group's return on equity of 9.56% beat RUA Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Creo Medical Group88.33% 9.56% -20.09%
RUA Life Sciences -3.26%-2.03%-17.50%

Summary

Creo Medical Group beats RUA Life Sciences on 8 of the 12 factors compared between the two stocks.

Get Creo Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CREO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CREO vs. The Competition

Export
MetricCreo Medical GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£58.98M£2.13B£6.44B£2.81B
Dividend YieldN/A2.67%2.75%6.08%
P/E Ratio-14.3014.1421.50365.45
Price / Sales9.83123.89581.0887,990.19
Price / Cash2.4315.9943.1327.89
Price / Book1.094.5110.517.75
Net Income-£25.04M£144.75M£3.56B£5.89B
7 Day Performance24.35%-0.20%2.96%1.40%
1 Month Performance19.17%0.65%4.40%4.10%
1 Year Performance-11.32%4.98%37.72%69.73%

Creo Medical Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CREO
Creo Medical Group
N/AGBX 14.25
-1.7%		GBX 40
+180.7%		+5.5%£58.78M£6MN/A279
EKF
EKF Diagnostics
N/AGBX 26.60
-5.0%		GBX 35
+31.6%		+6.2%£120.54M£51.56M56.60356
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57MN/A65
NCYT
Novacyt
N/AGBX 49.80
-0.4%		N/A+0.8%£36.05M£20.03MN/A120
IHC
Inspiration Healthcare Group
N/AGBX 29.21
+0.4%		N/A+52.6%£26.09M£45.20MN/A224

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:CREO) was last updated on 5/28/2026 by MarketBeat.com Staff.
From Our Partners
BNZI Breakout Watch: AI Growth Meets Turnaround Setup!
Banzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, ...
Huge Alerts | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The math on the SpaceX IPO is broken
SpaceX is expected to go public at a $1.75 trillion valuation. For investors to see a 10x return, the company ...
Weiss Ratings | Sponsoredtc pixel
A 25,000% opportunity
Angel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...
The Oxford Club | Sponsoredtc pixel
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel
This Tech Could Be Bigger Than Apple, Amazon, and Microsoft Combined
A breakthrough technology backed by Elon Musk, Sam Altman, and Nvidia CEO Jensen Huang may hold the answer to ...
Altimetry | Sponsoredtc pixel
The AI Shakeout Is Coming — Most Investors Won’t Survive
Every major tech shift follows the same pattern: hype, a brutal shakeout, then a handful of winners that take ...
Prosperity Research | Sponsoredtc pixel
SMX Could Be One of the Most Interesting Small Caps Right Now
SMX (Security Matters) Public Limited is developing molecular-level markers embedded into plastics, fuels, met...
Smallcaps Daily | Sponsoredtc pixel